CNR Institutional Research Information System

SINI, MARIA CRISTINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
AS - Asia 2.581
NA - Nord America 1.123
EU - Europa 717
SA - Sud America 438
AF - Africa 40
OC - Oceania 3
Totale 4.902
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.065
SG - Singapore 1.053
CN - Cina 573
BR - Brasile 362
HK - Hong Kong 302
IT - Italia 262
VN - Vietnam 250
FR - Francia 133
JP - Giappone 133
NL - Olanda 101
KR - Corea 81
DE - Germania 53
IN - India 48
GB - Regno Unito 39
BD - Bangladesh 28
FI - Finlandia 25
CA - Canada 24
AR - Argentina 21
ID - Indonesia 17
IL - Israele 16
ZA - Sudafrica 16
MX - Messico 15
AT - Austria 14
IE - Irlanda 14
IQ - Iraq 14
EC - Ecuador 13
CO - Colombia 11
PL - Polonia 10
VE - Venezuela 10
RU - Federazione Russa 9
KE - Kenya 8
SA - Arabia Saudita 8
TR - Turchia 8
UY - Uruguay 8
PK - Pakistan 7
CZ - Repubblica Ceca 6
MA - Marocco 6
PY - Paraguay 6
UA - Ucraina 6
ES - Italia 5
JM - Giamaica 5
LT - Lituania 5
PH - Filippine 5
CH - Svizzera 4
KZ - Kazakistan 4
PE - Perù 4
UZ - Uzbekistan 4
AL - Albania 3
DZ - Algeria 3
HN - Honduras 3
HU - Ungheria 3
MY - Malesia 3
NO - Norvegia 3
SE - Svezia 3
TH - Thailandia 3
TT - Trinidad e Tobago 3
AM - Armenia 2
AZ - Azerbaigian 2
BG - Bulgaria 2
BO - Bolivia 2
CR - Costa Rica 2
DO - Repubblica Dominicana 2
EE - Estonia 2
GT - Guatemala 2
LB - Libano 2
LK - Sri Lanka 2
LV - Lettonia 2
NP - Nepal 2
NZ - Nuova Zelanda 2
OM - Oman 2
PT - Portogallo 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
TN - Tunisia 2
AE - Emirati Arabi Uniti 1
AO - Angola 1
AU - Australia 1
BB - Barbados 1
BE - Belgio 1
BH - Bahrain 1
BN - Brunei Darussalam 1
BY - Bielorussia 1
CI - Costa d'Avorio 1
CL - Cile 1
CU - Cuba 1
CY - Cipro 1
GE - Georgia 1
HR - Croazia 1
JO - Giordania 1
KG - Kirghizistan 1
KH - Cambogia 1
LU - Lussemburgo 1
ME - Montenegro 1
MM - Myanmar 1
MW - Malawi 1
NG - Nigeria 1
PS - Palestinian Territory 1
QA - Qatar 1
RO - Romania 1
RS - Serbia 1
Totale 4.900
Salva come PNG Salva come JPEG
Città #
Singapore 602
Santa Clara 303
Hong Kong 299
Hefei 188
San Jose 146
Tokyo 119
Lauterbourg 111
Beijing 105
Ho Chi Minh City 96
Ashburn 90
Seoul 78
Hanoi 66
Los Angeles 62
Dallas 56
São Paulo 36
Cavallino 29
New York 29
Cagliari 18
Council Bluffs 18
Milan 18
Genoa 16
Dublin 14
Helsinki 14
Amsterdam 13
Rio de Janeiro 13
Rome 13
Frankfurt am Main 12
Minamishinagawa 12
Orem 12
Guangzhou 11
Buffalo 10
Florence 10
Nuremberg 10
Düsseldorf 9
Johannesburg 9
Naples 9
Phoenix 9
Vienna 9
Curitiba 8
Manchester 8
Montreal 8
Nairobi 8
Porto Alegre 8
Sala Baganza 8
Bengaluru 7
Chennai 7
Hải Dương 7
Jakarta 7
Montevideo 7
Mumbai 7
Salvador 7
Turku 7
Belo Horizonte 6
Boston 6
Brooklyn 6
London 6
Munich 6
Da Nang 5
Denver 5
Duque de Caxias 5
Goiânia 5
Houston 5
Quảng Ninh 5
Riyadh 5
San Francisco 5
Sassari 5
Shanghai 5
Toronto 5
Baghdad 4
Bari 4
Betim 4
Boardman 4
Casablanca 4
Chicago 4
Dhaka 4
Haiphong 4
Hortolândia 4
Kingston 4
Lappeenranta 4
Ludwigsburg 4
Maceió 4
Poplar 4
Quận Một 4
Recife 4
San Gregorio di Catania 4
Santa Maria 4
Seattle 4
Tashkent 4
Tel Aviv 4
Thái Nguyên 4
Turin 4
Warsaw 4
Asunción 3
Biên Hòa 3
Brasília 3
Bắc Giang 3
Calgary 3
Campinas 3
Can Tho 3
Chandigarh 3
Totale 2.983
Salva come PNG Salva come JPEG
Nome #
Comparison between Three Different Techniques for the Detection of EGFR Mutations in Liquid Biopsies of Patients with Advanced Stage Lung Adenocarcinoma 92
Progetto Alternanza scuola lavoro 2016 - Liceo Scientifico G.Marconi di Sassari 78
Il CSCC: aspetti distintivi della patologia 76
Combination of mutations in genes controlling DNA repair and high mutational load plays a prognostic role in pancreatic ductal adenocarcinoma (PDAC): a retrospective real-life study in Sardinian population 74
Functionals interactions of the MAPK-ERK gene pathway in melanoma pathogenesis. 73
Antidiabetic potential of vanadium complexes combined with olive leaf extracts: a viable approach to reduce metal toxicity 73
Germline and somatic NGS-based analysis on BRCA-related tumors 72
Multiple primary melanomas from same patients present discrepant somatic alterations in main candidate genes 70
A Functional Mammalian Target of Rapamycin Complex 1 Signaling Is Indispensable for c-Myc-Driven Hepatocarcinogenesis 69
nalysis of Fanconi anemia genes in colorectal cancer. 65
Idiopathic pulmonary fibrosis (IPF) and lung cancer 65
Microsatellite instability in melanocytic skin lesions (benign nevi, dysplastic nevi, and primary melanomas along with their metastases) 64
Dietary compounds and cutaneous malignant melanoma: recent advances from a biological perspective 63
Landscape of immune-related signatures induced by targeting of different epigenetic regulators in melanoma: implications for immunotherapy 63
Genetic and molecular alterations in pancreatic cancer progression by next generation sequencing 63
Molecular landscape profile of melanoma 62
Role of argininosuccinate synthetase (ASS) expression in response to arginine deiminase (ADI) in melanoma cell lines 61
KIT and PDGFRa mutational patterns in Sardinian patients with gastrointestinal stromal tumors 61
Genetic Instability Markers in Cancer 59
Epidemiology and Genetic Susceptibility of Breast and Ovarian Cancer in Sardinian Population 59
Comparison of BRAF Mutation Screening Strategies in a Large Real-Life Series of Advanced Melanoma Patients 59
BRAFV600 variant allele frequency predicts outcome in metastatic melanoma patients treated with BRAF and MEK inhibitors 59
Liquid biopsy in clinical oncology 59
BRAF Mutations and Dysregulation of the MAP Kinase Pathway Associated to Sinonasal Mucosal Melanomas 59
Global prognostic impact of driver genetic alterations in patients with lung adenocarcinoma: a real-life study 58
Genetic alterations in main candidate genes during melanoma progression. 56
Epidemiology and genetic susceptibility of malignant melanoma in North Sardinia, Italy 52
Different pathogenetic mechanisms are underlying molecular alterations in fanconi and mismatch DNA repair genes among patients with colorectal carcinoma 51
EGFR, KRAS, BRAF, ALK, and cMET genetic alterations in 1440 Sardinian patients with lung adenocarcinoma 51
BRAF testing techniques in the management of patients with advanced malignant melanoma: a real world comparative study 50
Are Molecular Alterations Linked to Genetic Instability Worth to Be Included as Biomarkers for Directing or Excluding Melanoma Patients to Immunotherapy? 50
Comparison of BRAF testing techniques in patients with advanced malignant melanoma: a real-life study. 50
Heterogeneous pathogenesis of melanoma: BRAF mutations and beyond 49
Mutation analysis of candidate genes in melanoma-prone families: Evidence of different pathogenetic mechanisms at chromosome 9P21 48
Ngs-based analysis of atypical deep penetrating nevi 48
Germline and somatic mutations in patients with multiple primary melanomas: a next generation sequencing study 48
Genetic alterations at chromosome 9p21 and melanoma progression. 47
Quality assessment of a clinical next-generation sequencing melanoma panel within the Italian Melanoma Intergroup (IMI) 41
Mammary-like adenocarcinoma of the vulva: a rare case report with next generation sequencing 41
Vitamin D status and risk for malignant cutaneous melanoma: recent advances 40
Mutations in main candidate genes (egfr, kras, braf) among patients with non-small-cell lung cancer from Sardinia 40
Complete and Durable Response to Combined Chemo/Radiation Therapy in EGFR Wild-Type Lung Adenocarcinoma with Diffuse Brain Metastases 40
Chromosomal abnormalities and microsatellite instability in sporadic endometrial cancer 39
Dermoscopy and confocal microscopy for metachronous multiple melanomas: morphological, clinical, and molecular correlations 38
Mutational concordance between primary and metastatic melanoma: a next-generation sequencing approach 38
Comparison of multiple tumor lesions from the same melanoma patients using next-generation sequencing (NGS) approaches 37
Analysis of candidate genes through a proteomics-based approach in primary cell lines from malignant melanomas and their metastases 37
Analyses of key-regulator genes in melanoma susceptibility and pathogenesis among patients from south Italy. 35
Induction of arginosuccinate synthetase (ASS) expression affects the antiproliferative activity of arginine deiminase (ADI) in melanoma cells. 35
Impact of tissue type and content of neoplastic cells in the specimen on the quality of epidermal growth factor receptor mutation analysis among patients with lung adenocarcinoma. 34
Analysis of the MAPK-ERK gene Pathway in primary and metastatic melanoma cell lines 34
ERCC1 polymorphisms as prognostic markers in T4 breast cancer patients treated with platinum-based chemotherapy 34
Long non-coding RNA CASC2 in human cancer 34
Assessment of germline and somatic alterations in main candidate genes among patients with multiple primary melanoma 33
Identification of candidate transcripts at chromosomes 10q25-q26 and 9p21 in endometrial cancer (EC) and malignant melanoma (MM). 33
Molecular analysis of Fanconi anemia (FA) and mismatch repair (MMR) genes in patients with colorectal carcinoma 33
Female Adnexal Tumors of probable Wolffian Origin (FATWO): a case series with next-generation sequencing mutation analysis 32
A novel candidate gene in human endometrial cancer at chromosome 10q26 32
BRAF/NRAS mutation frequencies among primary tumors and metastases in patients with melanoma 32
Molecular classification for the management of melanoma patients. 30
NEMO-binding domain peptide inhibits proliferation of human melanoma cells. 30
Prevalence of BRAF and NRAS mutations in primary tumours and different types of metastasis among melanoma patients 30
Mutation analysis of known candidate genes and evaluation of protein expression through proteomic approaches in malignant melanoma 30
Vitamin D status and risk for malignant cutaneous melanoma: recent advances 30
Immunoreactivity for Ca 125 and INI 1 loss of expression are useful markers in the diagnosis of vulvar proximal-type epithelioid sarcomas: Report of two cases 30
NEMO-binding domain peptide inhibits proliferation of human melanoma cells. 30
Genetic alterations in main candidate genes during melanoma progression 30
Overexpression of h-prune in breast cancer is correlated with advanced disease status 29
Activating PIK3CA mutations coexist with BRAF or NRAS mutations in a limited fraction of melanomas 29
BRCA1 and BRCA2 analysis in Sardinian breast cancer families 29
CDKN2A and MC1R analysis in amelanotic and pigmented melanoma 29
BRAF-NRAS mutation analysis among primary tumors and metastases at different sites from patients with melanoma 29
Evaluation of genetic heterogeneity in paired lymph node metastases from melanoma patients using next-generation sequencing (NGS) approaches 29
Fanconi genes may contribute to melanoma pathogenesis. 28
Identification of predictive factors for the occurrence of predisposing MLH1 and MSH2 germline mutations among Sardinian patients with colorectal carcinoma 28
Pattern and distribution of BRAF/NRAS and P16CDKN2A mutations among primary an secondary lesions in melanoma patients [abstract]. 28
BRCA1 and BRCA2 mutation analysis in breast cancer families from Sardinia 28
Sequential accumulation of molecular alterations at the chromosome 9p21 during development and progression of melanoma. 27
Germline mutations in candidate genes among patients with cutaneous melanoma from Sardinia. 27
Multiple molecular pathways in melanomagenesis: Characterization of therapeutic targets 27
CORRELATION BETWEEN ARGINOSUCCINATE SYNTHETASE (ASS) EXPRESSION AND TREATMENT WITH ARGININE DEIMINASE (ADI) IN MELANOMA CELL LINES. 27
Expression of arginino-succinate synthetase (ASS) and response to arginine deiminase (ADI) treatment in a series of melanoma cell lines. AACR-NCI-EORTC 26
Deregulated c-Myc requires a functional HSF1 for experimental and human hepatocarcinogenesis 26
Origin and distribution of the BRCA2-8765delAG mutation in breast cancer 26
Discrepant alterations in main candidate genes among multiple primary melanomas 26
The EGF 61A>G polymorphism has no role in nevi formation and melanoma pathogenesis within italian population 26
Identification of a novel candidate gene, CASC2, in a region of common allelic loss at chromosome 10q26 in human endometrial cancer. 26
Mutation analysis of candidate genes in familial cases with malignant melanoma: identification of an additional susceptibility region at chromosome 9p21 26
Cytogenetic analysis at chromosome 9p21 on tissue sections from patients with malignant melanoma 26
Liquid biopsy in prostate cancer: A multidisciplinary expert consensus statement 26
Molecular alterations at chromosome 9p21 in melanocytic nevi and melanoma. 26
Role of key-regulator genes in melanoma susceptibility and pathogenesis among patients from South Italy 25
Downregulation of the CASC2a gene in endometrial cancer. 25
BRCA1 and BRCA2 mutation analysis through an evaluation clinic program among Sardinian breast cancer patients. 25
Tumour microenvironment heterogeneity in primary and metastatic paired melanoma samples and its correlation with genetic features and prognosis 24
Squamous cell carcinoma arising in mature cystic teratoma of the ovary: Report of two cases with molecular analysis 24
Epidemiological and genetic factors underlying melanoma development in Italy 24
Identification of a novel candidate gene, MENC, in a consensus region of allelic deletion at chromosome 10q26 in human endometrial cancer. 24
Proteomics and expression analysis for identification of new candidate genes in melanoma progression 23
Germline mutations in Brca1 and Brca2 genes among Sardinian breast cancer patients 23
Totale 4.159
Salva come PNG Salva come JPEG
Categoria #
all - tutte 16.245
article - articoli 12.434
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 720
Totale 29.399
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2023/202421 0 0 0 0 0 0 0 0 4 0 13 4
2024/20251.823 17 8 109 70 310 83 37 102 67 123 463 434
2025/20263.201 153 264 302 393 519 139 548 272 236 239 136 0
Totale 5.045